September 22, 2025

Hot Dogs and Thimerosal: What’s Really at Stake?

At a tense CDC meeting, skeptics aired old claims while experts warned that trust, not safety, is the issue at hand.

KFF Health News

September 18, 2025

'Integrity Cannot Be Replaced': Ousted CDC Leader Speaks Out

Testimony from former CDC leadership highlighted differences with federal health officials on the process for reviewing and implementing vaccine policies.

KFF Health News

September 16, 2025

State’s Largest HIV Outbreak Raises Alarms

Public health experts cite syringe shortages and encampment clearings as drivers of Penobscot County’s historic HIV outbreak.

KFF Health News

September 16, 2025

RFK Jr. Panel Weighs Hepatitis B Delay

Advisory committee members may push to move the hepatitis B vaccine to age 4, despite warnings from clinicians.

KFF Health News

September 02, 2025

Bile Acid Biomarker Stratifies HBV Cirrhosis

Antiviral therapy lowers taurochenodeoxycholic acid concentrations in patients with hepatitis B virus cirrhosis, reflecting changes in bile acid balance with viral suppression.

Conexiant

June 24, 2025

Shorter Antibiotic Courses: Safe for DFO?

A new meta-analysis aims to clarify optimal antibiotic duration for diabetic foot osteomyelitis

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 21, 2025

Metabolic Diseases Weaken Hepatitis B Treatment Response

The number of metabolic conditions may shape outcomes in hepatitis B therapy.

Conexiant